New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 28, 2014
12:11 EDTBMY, NEStocks with call strike movement; BMY NE
Bristol-Myers (BMY) June 60 call option implied volatility decreased 4% to 27, Noble Corp. (NE) June 38 call option implied volatility increased 2% to 27 according to IVolatility.
News For BMY;NE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
October 30, 2014
05:49 EDTBMYStocks with implied volatility movement; ARCP BMY
Subscribe for More Information
October 29, 2014
17:08 EDTNENoble Corp. reports Q3 EPS 57c, consensus 53c
Subscribe for More Information
15:53 EDTNENotable companies reporting after market close
Subscribe for More Information
October 28, 2014
15:01 EDTNENoble Corp. to seek shareholder approval for 15% share repurchase
Subscribe for More Information
09:20 EDTNEOn The Fly: Pre-market Movers
Subscribe for More Information
08:16 EDTNENoble Corp. to pursue development of MLP
Subscribe for More Information
08:13 EDTNENoble Corp. authorizes vote on share repurchase of up to 37M shares
Noble Corporation's Board has authorized the company to seek approval from its shareholders to increase the company's authority to repurchase its outstanding shares. The approval is expected to be sought at a Special Meeting of Shareholders scheduled for December 22. The company intends to file a preliminary proxy statement with the SEC with a proposal to authorize the potential repurchase of up to an aggregate of 37M shares, or approximately 15% of the company's ordinary shares outstanding. This authorization would be in addition to the Company's existing share repurchase authorization under which approximately 4.8M shares remained available for purchase as of September 30.
07:04 EDTBMYBristol-Myers enters agreement to acquire F-star Alpha, rights to FS102
Subscribe for More Information
07:03 EDTBMYBristol-Myers enters agreement to acquire F-star Alpha, rights to FS102
October 27, 2014
20:54 EDTBMYLeerink's major pharma analyst holds an analyst/industry conference call
Subscribe for More Information
October 24, 2014
16:02 EDTBMYOptions Update; October 24, 2014
Subscribe for More Information
11:15 EDTBMYBristol-Myers says has capacity for large deal
Subscribe for More Information
10:42 EDTBMYBristol-Myers sees coming in closer to high end of FY14 EPS guidance
Subscribe for More Information
10:10 EDTBMYBristol-Myers to host conference call
Conference call to review data presented at the Chicago Multidisciplinary Symposium on Thoracic Oncology (CMSTO) will be held on October 31 at 2:30 pm. Webcast Link
07:35 EDTBMYBristol-Myers reports Q3 Eliquis revenue $216M
Reports Q3 Baraclude revenue $325M, Sprycel revenue $385M, Yervoy revenue $350M. Reports Q3 Abilify revenue $449M, Orencia revenue $444M.
07:33 EDTBMYBristol-Myers confirms FY14 adjusted EPS view $1.70-$1.80, consensus $1.78
Cuts FY14 GAAP EPS view to $1.15-$1.25 from $1.50-$1.60. Both GAAP and non-GAAP guidance assume current exchange rates and that the R&D tax credit will be extended by Congress in 2014. Sees FY14 worldwide revenue $15.2B-$15.8B, consensus $15.58B. Also sees: Full-year gross margin as a percentage of revenues between 75% and 76%. Advertising and promotion expense decreasing in the mid-teen-digit range. Marketing, sales and administrative expenses decreasing in the mid-single-digit range. Research and development expenses growing in the mid-single-digit range. An effective tax rate of 19% - 20%.
07:31 EDTBMYBristol-Myers reports Q3 adjusted EPS 45c, consensus 42c
Subscribe for More Information
October 23, 2014
15:39 EDTBMYNotable companies reporting before tomorrow's open
Subscribe for More Information
October 21, 2014
07:15 EDTBMYFDA to hold workshop on breast cancer drug development
Subscribe for More Information
October 20, 2014
07:19 EDTBMYIBC Life Sciences to hold a conference
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use